Arcus Biosciences Inc (RCUS) Stock Price, Quote, News & History

RCUSNYSE
$30.76
-0.81-2.57%
At close: Aug 25, 5:00 PM EST
$30.76
-0.81-2.57%
Pre-Market: 5:04 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-474.00M
Investing Cash Flow (TTM)
63.00M
Financing Cash Flow (TTM)
313.00M
Free Cash Flow (TTM)
-475.00M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-98.00M

Analyst Trends and Forecast

2
1
May
1
Jun
1
Jul
1
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$3.33B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
31.31
PB Ratio (TTM)
8.44
Earnings Yield % (TTM)
-12.81%
Earnings Yield % (FWD)
-12.03%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.64

Company Debt

Total Debt
$101.00M
LT Debt
$101.00M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$150.00M
Debt to Equity
0.25
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$30.76
Volume / Avg.
0 / 1.30M
Day Range
- - -
52 Wk Range
10.07 - 31.74
Market Cap
$3.87B
P/E Ratio
-
Dividend Yield
-
Exchange
NYSE
RSI
54
Short Interest
18.12%
Days to Cover
12.3

About

Sector
Health Care
Industry
Biotechnology
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casd...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Arcus Biosciences (RCUS) stock?

A

You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcus Biosciences (RCUS) competitors?

Q

What is the forecast, or price target, for Arcus Biosciences (RCUS) stock?

A

Arcus Biosciences has a consensus price target of $35.47.

Q

What is the current price for Arcus Biosciences (RCUS)?

A

The stock price for Arcus Biosciences (NYSE: RCUS) is $30.76 last updated August 26, 2026 at 4:00 PM EDT.

Q

Does Arcus Biosciences (RCUS) pay a dividend?

A

There are no upcoming dividends for Arcus Biosciences.

Q

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

A

Arcus Biosciences does not have any upcoming earnings scheduled.

Q

Is Arcus Biosciences (RCUS) going to split?

A

There is no upcoming split for Arcus Biosciences.

Q

What sector and industry does Arcus Biosciences (RCUS) operate in?

A

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.